IMC is the most undervalued biotech
most biotechs aren’t even making revenue from
their lead drug. This will most likely get taken over or perhaps I’ll wait for FDA approval to come. which is pretty much certain given IMC has TGA approved, and given how it works (as per sales data)
what we are trading at now is laughable compared to peers.
Ill be hoping for $1
Add to My Watchlist
What is My Watchlist?
